Grants

Faculty members at the Center for Advanced Pain Studies have over $25 million dollars of grants or contracts to study chronic pain and migraine. Our ongoing goal is to gain federal research grants to create basic science discoveries that will lead to the next generation of therapeutics.

Principal Investigator	Funding Agency	Title
Burton, Michael	Advanced Neuromodulation Systems	SRA: High Content Pain Circuit Cell Culture System
Burton, Michael	NIH-R21	The Role of Cell-specific TLR4 in Diabetic Peripheral Neuropathy
Burton, Michael	NIH-R35	Mechanisms Involved in Postoperative Recovery: A Focus on Pain, Delirium, and Neuroinflammation
Dussor, Greg	1910 Genetics-SUB	STTR Phase I: Development of Selective Calpain-1 Inhibitors for Chronic Pain
Dussor, Greg	Marine Biological Lab-Sub	Site-directed RNA Editing of Nav1.7 as a Novel Analgesic
Dussor, Greg	Univ. of Wisconsin-Madison-SUB	Profiling Translation in Nociceptor Plasticity
Dussor, Greg	Raft Pharmaceuticals	STTR: Targeting Lipid Rafts for Treatment of Migraine
Hong, Veronica	NIH-F31	Sigma 2 Receptor (TMEM97): Investigating the Peripheral Role of this Novel Therapeutic Target for Pain
Kolber, Ben	NIH-R01	Impact of Amygdala Lateralization on Processing and Modulation of Bladder Pain
Kolber, Ben	Communities Foundation of Texas	The University of Texas Foundation Grant Agreement, Enhance Neuroscience Undergraduate Research Experiences at UTD (ENSURE)
Kolber, Ben	NIH-R16	High Content Analgesic Screening from Human Nociceptors
Lenert, Melissa	NIH-F99	Identification of Sex Differences in Monocytes and Metabolism in the Maintenance of Chronic Muscle Pain
Lewter, Lakeisha	NIH-F32	The Impact of Amygdala CGRP Receptors on the Development of Persistent Bladder Pain
Lewter, Lakeisha	Burroughs Wellcome Fund	Licensing Accelerator Pilot Award-NIH Protease Activated Receptor Type 2 Targeting for Migraine Pain
Price, Theodore	Grunenthal GmbH	SRA: Advancement of translational pain research through the transcriptomic analysis of the dorsal root ganglia using cutting edge sequencing technologies
Price, Theodore	Grunenthal GmbH	IPA SRA: Testing Agreement: Insights into the function of PRDM12 through transcriptomic analysis of human neuronal cultures derived from DRG after knock-down of PRDM12 using ASOs
Price, Theodore	NIH	Diversity Supplement to Project 6793
Price, Theodore	Thomas Jefferson University-Subaward	Extracellular Mechanism Regulating Synaptic Function and Pain Plasticity
Price, Theodore	Thomas Jefferson University – Subaward	Novel Mechanisms Regulating Protein Interaction and Pain
Price, Theodore	MD Anderson Cancer Center-Subaward	Validation of Fibroblast-derived PI16 as a Novel Target for Pain Treatment
Price, Theodore	MD Anderson Cancer Center-Subaward	Anatomic, Physiologic and Transcriptomic Mechanisms of Neuropathic Pain in Human DRG
Price, Theodore	UTSW-Subaward	Mechanisms of cough in Mycobacterium tuberculosis transmission
Price, Theodore	4E Therapeutics	SBIR: Development and Optimization of MNK Inhibitors for the Treatment of Neuropathic Pain
Price, Theodore	Hoba Therapeutics ApS	IPA SRA: Testing Agreement: Profiling of human Meteorin (HB-086) activity in human DRGs
Price, Theodore	University of Washington-Subaward	Identifying Novel Therapeutic Targets for Chronic Neck Pain: RNA-sequencing in Human Painful Atlanto-axial Arthropathy
Price, Theodore	Allergan Inc.	IPA SRA: Evaluation of novel recombinant molecules in primary human DRGs
Price, Theodore	Bellus Health Cough Inc.	SRA: P2RX2 and P2RX3 expression in human gustatory neurons
Price, Theodore	NIH-U-19	Human Nociceptor and Spinal Cord Molecular Signature Center
Price, Theodore	Hoba Therapeutics ApS	IPA SRA: Testing Agreement: Profiling of human Meteorin (HB-086) activity in human DRGs
Price, Theodore	Doloromics-SRA	SRA: Human DRG Target Validation
Sadler, Katelyn	NIH-R00	Sickle Cell Disease Gut Dysbiosis Effects on CNS Pain Processing